Loading…

Proapoptotic and antiapoptotic effects of hyperglycemia : role of insulin signaling

Glucose toxicity is an important initiator of cardiovascular disease, contributing to the development of insulin resistance, impaired contractile function, abnormal energy metabolism, cardiomyocyte and endothelial cell death, coronary heart disease, and heart failure. High blood glucose can, however...

Full description

Saved in:
Bibliographic Details
Published in:Canadian journal of physiology and pharmacology 2008-04, Vol.86 (4), p.166-172
Main Authors: RICCI, Craig, CHIAN JU JONG, SCHAFFER, Stephen W
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 172
container_issue 4
container_start_page 166
container_title Canadian journal of physiology and pharmacology
container_volume 86
creator RICCI, Craig
CHIAN JU JONG
SCHAFFER, Stephen W
description Glucose toxicity is an important initiator of cardiovascular disease, contributing to the development of insulin resistance, impaired contractile function, abnormal energy metabolism, cardiomyocyte and endothelial cell death, coronary heart disease, and heart failure. High blood glucose can, however, paradoxically protect the heart against a variety of insults, including ischemia, hypoxia, and calcium overload. To provide information on the underlying basis of these divergent actions of high glucose, the present study examined the hypothesis that the adverse effects of high glucose are linked to impaired insulin signaling, leading to a reduction in the levels of cytoprotective factors, and that the beneficial effects of high glucose occur in the absence of insulin and result in an improvement in Akt signaling. This hypothesis was evaluated by using an in vitro cardiomyocyte model that is amenable to manipulations in glucose and insulin. Prolonged exposure of the isolated neonatal cardiomyocyte to medium containing insulin and high glucose led to increased susceptibility to angiotensin II-mediated apoptosis, an effect associated with reduced levels of phospho-Akt and an increased Bax/Bcl-2 ratio. By contrast, exposure to high glucose levels in the absence of insulin rendered the cardiomyocyte resistant to angiotensin II-mediated apoptosis. Because the beneficial effects of high glucose were associated with elevations in phospho-Akt and Bcl-2 content, the cardioprotective activity of high glucose resembles the actions of insulin. Hence, the activation state of Akt is largely determined by the activity of insulin and other growth factors. Because high glucose diminishes insulin signaling, it reduces phospho-Akt levels and renders the cell susceptible to damaging insults. In the absence of insulin, however, the natural activity of high glucose is unmasked. As a result, Akt signaling is increased and the cell is rendered resistant to cell death.
doi_str_mv 10.1139/Y08-021
format article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_journals_221727591</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A180697328</galeid><sourcerecordid>A180697328</sourcerecordid><originalsourceid>FETCH-LOGICAL-g438t-6f8a9cd74e98d9632ebb1211c0cfd18d0daa9925ff55240b9fe14c89380f33203</originalsourceid><addsrcrecordid>eNqVkV1LwzAUhoMobk7xH0gRvPCiMx_tmng3hh-DoeL0wquSpUnN6JouScH9eyObzoE3khNy8vKcl_AGgFME-wgRdvUGaQwx2gNdhGEaZ2mC9kEXwiAnGOEOOHJuHq4DSugh6CCahMJpF0yfrOGNabzxWkS8LsL2eqtIpaTwLjIqel810pbVSsiF5tF1ZE0lv3Rdu7bSdeR0WfPQlMfgQPHKyZPN2QOvtzcvo_t48ng3Hg0ncZkQ6uOBopyJIkskowUbECxnM4QRElCoAtECFpwzhlOl0hQncMaURImgjFCoCMGQ9MD52rexZtlK5_O5aW14g8sxRhnOUoYCFK-hklcy17Uy3nJRylpaXplaKh3kIaJwwDKC6dZ0hxeNXua_of4fUFhFyEb86Xq5MxAYLz98yVvn8vH0-R_swy57tomgnS1kkTdWL7hd5d8fHICLDcCd4JWyvBba_XAhxYzBBJNPoo2u8A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>221727591</pqid></control><display><type>article</type><title>Proapoptotic and antiapoptotic effects of hyperglycemia : role of insulin signaling</title><source>EBSCOhost SPORTDiscus with Full Text</source><creator>RICCI, Craig ; CHIAN JU JONG ; SCHAFFER, Stephen W</creator><creatorcontrib>RICCI, Craig ; CHIAN JU JONG ; SCHAFFER, Stephen W</creatorcontrib><description>Glucose toxicity is an important initiator of cardiovascular disease, contributing to the development of insulin resistance, impaired contractile function, abnormal energy metabolism, cardiomyocyte and endothelial cell death, coronary heart disease, and heart failure. High blood glucose can, however, paradoxically protect the heart against a variety of insults, including ischemia, hypoxia, and calcium overload. To provide information on the underlying basis of these divergent actions of high glucose, the present study examined the hypothesis that the adverse effects of high glucose are linked to impaired insulin signaling, leading to a reduction in the levels of cytoprotective factors, and that the beneficial effects of high glucose occur in the absence of insulin and result in an improvement in Akt signaling. This hypothesis was evaluated by using an in vitro cardiomyocyte model that is amenable to manipulations in glucose and insulin. Prolonged exposure of the isolated neonatal cardiomyocyte to medium containing insulin and high glucose led to increased susceptibility to angiotensin II-mediated apoptosis, an effect associated with reduced levels of phospho-Akt and an increased Bax/Bcl-2 ratio. By contrast, exposure to high glucose levels in the absence of insulin rendered the cardiomyocyte resistant to angiotensin II-mediated apoptosis. Because the beneficial effects of high glucose were associated with elevations in phospho-Akt and Bcl-2 content, the cardioprotective activity of high glucose resembles the actions of insulin. Hence, the activation state of Akt is largely determined by the activity of insulin and other growth factors. Because high glucose diminishes insulin signaling, it reduces phospho-Akt levels and renders the cell susceptible to damaging insults. In the absence of insulin, however, the natural activity of high glucose is unmasked. As a result, Akt signaling is increased and the cell is rendered resistant to cell death.</description><identifier>ISSN: 0008-4212</identifier><identifier>EISSN: 1205-7541</identifier><identifier>DOI: 10.1139/Y08-021</identifier><identifier>PMID: 18418425</identifier><identifier>CODEN: CJPPA3</identifier><language>eng</language><publisher>Ottawa, ON: National Research Council of Canada</publisher><subject>Angiotensin II - metabolism ; Animals ; Animals, Newborn ; Apoptosis ; bcl-2-Associated X Protein - metabolism ; Biological and medical sciences ; Cardiovascular diseases ; Cells, Cultured ; Complications and side effects ; Fundamental and applied biological sciences. Psychology ; Glucose - metabolism ; Hyperglycemia ; Hyperglycemia - metabolism ; Hyperglycemia - pathology ; Hyperglycemia - physiopathology ; Insulin ; Insulin - metabolism ; Insulin Resistance ; Kinases ; Myocytes, Cardiac - enzymology ; Myocytes, Cardiac - metabolism ; Myocytes, Cardiac - pathology ; Phosphorylation ; Physiological aspects ; Proto-Oncogene Proteins c-akt - metabolism ; Proto-Oncogene Proteins c-bcl-2 - metabolism ; Rats ; Rats, Wistar ; Risk factors ; Signal Transduction ; Studies ; Vertebrates: anatomy and physiology, studies on body, several organs or systems</subject><ispartof>Canadian journal of physiology and pharmacology, 2008-04, Vol.86 (4), p.166-172</ispartof><rights>2008 INIST-CNRS</rights><rights>COPYRIGHT 2008 NRC Research Press</rights><rights>Copyright National Research Council of Canada Apr 2008</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>309,310,314,780,784,789,790,23930,23931,25140,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=20379042$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18418425$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>RICCI, Craig</creatorcontrib><creatorcontrib>CHIAN JU JONG</creatorcontrib><creatorcontrib>SCHAFFER, Stephen W</creatorcontrib><title>Proapoptotic and antiapoptotic effects of hyperglycemia : role of insulin signaling</title><title>Canadian journal of physiology and pharmacology</title><addtitle>Can J Physiol Pharmacol</addtitle><description>Glucose toxicity is an important initiator of cardiovascular disease, contributing to the development of insulin resistance, impaired contractile function, abnormal energy metabolism, cardiomyocyte and endothelial cell death, coronary heart disease, and heart failure. High blood glucose can, however, paradoxically protect the heart against a variety of insults, including ischemia, hypoxia, and calcium overload. To provide information on the underlying basis of these divergent actions of high glucose, the present study examined the hypothesis that the adverse effects of high glucose are linked to impaired insulin signaling, leading to a reduction in the levels of cytoprotective factors, and that the beneficial effects of high glucose occur in the absence of insulin and result in an improvement in Akt signaling. This hypothesis was evaluated by using an in vitro cardiomyocyte model that is amenable to manipulations in glucose and insulin. Prolonged exposure of the isolated neonatal cardiomyocyte to medium containing insulin and high glucose led to increased susceptibility to angiotensin II-mediated apoptosis, an effect associated with reduced levels of phospho-Akt and an increased Bax/Bcl-2 ratio. By contrast, exposure to high glucose levels in the absence of insulin rendered the cardiomyocyte resistant to angiotensin II-mediated apoptosis. Because the beneficial effects of high glucose were associated with elevations in phospho-Akt and Bcl-2 content, the cardioprotective activity of high glucose resembles the actions of insulin. Hence, the activation state of Akt is largely determined by the activity of insulin and other growth factors. Because high glucose diminishes insulin signaling, it reduces phospho-Akt levels and renders the cell susceptible to damaging insults. In the absence of insulin, however, the natural activity of high glucose is unmasked. As a result, Akt signaling is increased and the cell is rendered resistant to cell death.</description><subject>Angiotensin II - metabolism</subject><subject>Animals</subject><subject>Animals, Newborn</subject><subject>Apoptosis</subject><subject>bcl-2-Associated X Protein - metabolism</subject><subject>Biological and medical sciences</subject><subject>Cardiovascular diseases</subject><subject>Cells, Cultured</subject><subject>Complications and side effects</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Glucose - metabolism</subject><subject>Hyperglycemia</subject><subject>Hyperglycemia - metabolism</subject><subject>Hyperglycemia - pathology</subject><subject>Hyperglycemia - physiopathology</subject><subject>Insulin</subject><subject>Insulin - metabolism</subject><subject>Insulin Resistance</subject><subject>Kinases</subject><subject>Myocytes, Cardiac - enzymology</subject><subject>Myocytes, Cardiac - metabolism</subject><subject>Myocytes, Cardiac - pathology</subject><subject>Phosphorylation</subject><subject>Physiological aspects</subject><subject>Proto-Oncogene Proteins c-akt - metabolism</subject><subject>Proto-Oncogene Proteins c-bcl-2 - metabolism</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Risk factors</subject><subject>Signal Transduction</subject><subject>Studies</subject><subject>Vertebrates: anatomy and physiology, studies on body, several organs or systems</subject><issn>0008-4212</issn><issn>1205-7541</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNqVkV1LwzAUhoMobk7xH0gRvPCiMx_tmng3hh-DoeL0wquSpUnN6JouScH9eyObzoE3khNy8vKcl_AGgFME-wgRdvUGaQwx2gNdhGEaZ2mC9kEXwiAnGOEOOHJuHq4DSugh6CCahMJpF0yfrOGNabzxWkS8LsL2eqtIpaTwLjIqel810pbVSsiF5tF1ZE0lv3Rdu7bSdeR0WfPQlMfgQPHKyZPN2QOvtzcvo_t48ng3Hg0ncZkQ6uOBopyJIkskowUbECxnM4QRElCoAtECFpwzhlOl0hQncMaURImgjFCoCMGQ9MD52rexZtlK5_O5aW14g8sxRhnOUoYCFK-hklcy17Uy3nJRylpaXplaKh3kIaJwwDKC6dZ0hxeNXua_of4fUFhFyEb86Xq5MxAYLz98yVvn8vH0-R_swy57tomgnS1kkTdWL7hd5d8fHICLDcCd4JWyvBba_XAhxYzBBJNPoo2u8A</recordid><startdate>20080401</startdate><enddate>20080401</enddate><creator>RICCI, Craig</creator><creator>CHIAN JU JONG</creator><creator>SCHAFFER, Stephen W</creator><general>National Research Council of Canada</general><general>NRC Research Press</general><general>Canadian Science Publishing NRC Research Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>ISN</scope><scope>ISR</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>P64</scope></search><sort><creationdate>20080401</creationdate><title>Proapoptotic and antiapoptotic effects of hyperglycemia : role of insulin signaling</title><author>RICCI, Craig ; CHIAN JU JONG ; SCHAFFER, Stephen W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g438t-6f8a9cd74e98d9632ebb1211c0cfd18d0daa9925ff55240b9fe14c89380f33203</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Angiotensin II - metabolism</topic><topic>Animals</topic><topic>Animals, Newborn</topic><topic>Apoptosis</topic><topic>bcl-2-Associated X Protein - metabolism</topic><topic>Biological and medical sciences</topic><topic>Cardiovascular diseases</topic><topic>Cells, Cultured</topic><topic>Complications and side effects</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Glucose - metabolism</topic><topic>Hyperglycemia</topic><topic>Hyperglycemia - metabolism</topic><topic>Hyperglycemia - pathology</topic><topic>Hyperglycemia - physiopathology</topic><topic>Insulin</topic><topic>Insulin - metabolism</topic><topic>Insulin Resistance</topic><topic>Kinases</topic><topic>Myocytes, Cardiac - enzymology</topic><topic>Myocytes, Cardiac - metabolism</topic><topic>Myocytes, Cardiac - pathology</topic><topic>Phosphorylation</topic><topic>Physiological aspects</topic><topic>Proto-Oncogene Proteins c-akt - metabolism</topic><topic>Proto-Oncogene Proteins c-bcl-2 - metabolism</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Risk factors</topic><topic>Signal Transduction</topic><topic>Studies</topic><topic>Vertebrates: anatomy and physiology, studies on body, several organs or systems</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>RICCI, Craig</creatorcontrib><creatorcontrib>CHIAN JU JONG</creatorcontrib><creatorcontrib>SCHAFFER, Stephen W</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Gale In Context: Canada</collection><collection>Gale In Context: Science</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Canadian journal of physiology and pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>RICCI, Craig</au><au>CHIAN JU JONG</au><au>SCHAFFER, Stephen W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Proapoptotic and antiapoptotic effects of hyperglycemia : role of insulin signaling</atitle><jtitle>Canadian journal of physiology and pharmacology</jtitle><addtitle>Can J Physiol Pharmacol</addtitle><date>2008-04-01</date><risdate>2008</risdate><volume>86</volume><issue>4</issue><spage>166</spage><epage>172</epage><pages>166-172</pages><issn>0008-4212</issn><eissn>1205-7541</eissn><coden>CJPPA3</coden><abstract>Glucose toxicity is an important initiator of cardiovascular disease, contributing to the development of insulin resistance, impaired contractile function, abnormal energy metabolism, cardiomyocyte and endothelial cell death, coronary heart disease, and heart failure. High blood glucose can, however, paradoxically protect the heart against a variety of insults, including ischemia, hypoxia, and calcium overload. To provide information on the underlying basis of these divergent actions of high glucose, the present study examined the hypothesis that the adverse effects of high glucose are linked to impaired insulin signaling, leading to a reduction in the levels of cytoprotective factors, and that the beneficial effects of high glucose occur in the absence of insulin and result in an improvement in Akt signaling. This hypothesis was evaluated by using an in vitro cardiomyocyte model that is amenable to manipulations in glucose and insulin. Prolonged exposure of the isolated neonatal cardiomyocyte to medium containing insulin and high glucose led to increased susceptibility to angiotensin II-mediated apoptosis, an effect associated with reduced levels of phospho-Akt and an increased Bax/Bcl-2 ratio. By contrast, exposure to high glucose levels in the absence of insulin rendered the cardiomyocyte resistant to angiotensin II-mediated apoptosis. Because the beneficial effects of high glucose were associated with elevations in phospho-Akt and Bcl-2 content, the cardioprotective activity of high glucose resembles the actions of insulin. Hence, the activation state of Akt is largely determined by the activity of insulin and other growth factors. Because high glucose diminishes insulin signaling, it reduces phospho-Akt levels and renders the cell susceptible to damaging insults. In the absence of insulin, however, the natural activity of high glucose is unmasked. As a result, Akt signaling is increased and the cell is rendered resistant to cell death.</abstract><cop>Ottawa, ON</cop><pub>National Research Council of Canada</pub><pmid>18418425</pmid><doi>10.1139/Y08-021</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0008-4212
ispartof Canadian journal of physiology and pharmacology, 2008-04, Vol.86 (4), p.166-172
issn 0008-4212
1205-7541
language eng
recordid cdi_proquest_journals_221727591
source EBSCOhost SPORTDiscus with Full Text
subjects Angiotensin II - metabolism
Animals
Animals, Newborn
Apoptosis
bcl-2-Associated X Protein - metabolism
Biological and medical sciences
Cardiovascular diseases
Cells, Cultured
Complications and side effects
Fundamental and applied biological sciences. Psychology
Glucose - metabolism
Hyperglycemia
Hyperglycemia - metabolism
Hyperglycemia - pathology
Hyperglycemia - physiopathology
Insulin
Insulin - metabolism
Insulin Resistance
Kinases
Myocytes, Cardiac - enzymology
Myocytes, Cardiac - metabolism
Myocytes, Cardiac - pathology
Phosphorylation
Physiological aspects
Proto-Oncogene Proteins c-akt - metabolism
Proto-Oncogene Proteins c-bcl-2 - metabolism
Rats
Rats, Wistar
Risk factors
Signal Transduction
Studies
Vertebrates: anatomy and physiology, studies on body, several organs or systems
title Proapoptotic and antiapoptotic effects of hyperglycemia : role of insulin signaling
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T16%3A06%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Proapoptotic%20and%20antiapoptotic%20effects%20of%20hyperglycemia%20:%20role%20of%20insulin%20signaling&rft.jtitle=Canadian%20journal%20of%20physiology%20and%20pharmacology&rft.au=RICCI,%20Craig&rft.date=2008-04-01&rft.volume=86&rft.issue=4&rft.spage=166&rft.epage=172&rft.pages=166-172&rft.issn=0008-4212&rft.eissn=1205-7541&rft.coden=CJPPA3&rft_id=info:doi/10.1139/Y08-021&rft_dat=%3Cgale_proqu%3EA180697328%3C/gale_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-g438t-6f8a9cd74e98d9632ebb1211c0cfd18d0daa9925ff55240b9fe14c89380f33203%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=221727591&rft_id=info:pmid/18418425&rft_galeid=A180697328&rfr_iscdi=true